| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | Amgen Inc. | Aug 12, 2026 | |
| Buy | AMGEN INC. CMN | Jun 30, 2026 | |
| Buy | AMGEN INC. CMN | Jun 16, 2026 | |
| Buy | Amgen Inc. | Jun 5, 2026 | |
| Buy | AMGEN INC. CMN | Jun 2, 2026 | |
| Buy | AMGEN INC CMN/GLOBALESETTLE/ | May 29, 2026 | |
| Buy | AMGEN INC CMN | May 19, 2026 | |
| Sell | AMGEN CMN | May 19, 2026 | |
| Buy | AMGEN INC CMN | May 15, 2026 | |
| Sell | AMGEN NOVA CORP CMN | May 15, 2026 |
This page tracks congressional stock trading activity in Amgen Inc. (AMGN) in the Healthcare sector. Disclosed Capitol has indexed 309 disclosed congressional trades involving AMGN. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of September 2026 — Disclosed Capitol has tracked 309 disclosed congressional trades in Amgen Inc. (AMGN) — 122:76 sell-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Aug 12, 2026 | Sheldon Whitehouse | D | Sell | $1,001 - $15,000 |
| Jun 30, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Jun 16, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Jun 5, 2026 | David J. Taylor | R | Buy | $1,001 - $15,000 |
| Jun 2, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| May 29, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| May 19, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| May 19, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| May 15, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| May 15, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
Across the 309 disclosed congressional trades in Amgen Inc. (AMGN), members of Congress have reported 76 buys and 122 sells. The average 30-day alpha vs. the S&P 500 is -0.63%.
As of August 2026, Amgen Inc. has 19 federal contract award records on file from USAspending.gov — most recently $66.0M from the Department of Health and Human Services on 2026-08-04.
| Award date | Agency | Amount |
|---|---|---|
| 2026-08-04 | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | $66.0M |
| 2026-03-06 | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | $60.0M |
| 2025-09-04 | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | $2.3M |
| 2025-07-15 | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | $90.0M |
| 2024-10-04 | Department of Veterans Affairs | -$64K |
| 2024-09-18 | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | $129.0M |
| 2024-08-08 | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | $274K |
| 2024-03-12 | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | $580K |
| 2023-10-01 | Department of Veterans Affairs | $129K |
| 2023-09-20 | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | $204.9M |
Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.
For fiscal year 2025, Amgen Inc. reported revenue of $36.75B and net income of $7.71B, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $10.05B, net income $2.38B.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.